Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management.

MLA

Chapman, M.John, et al. “Triglyceride-Rich Lipoproteins and High-Density Lipoprotein Cholesterol in Patients at High Risk of Cardiovascular Disease: Evidence and Guidance for Management.” European Heart Journal, vol. 32, no. 11, June 2011, pp. 1345–61. EBSCOhost, https://doi.org/10.1093/eurheartj/ehr112.

APA

Chapman, M. J., Ginsberg, H. N., Amarenco, P., Andreotti, F., Borén, J., Catapano, A. L., Descamps, O. S., Fisher, E., Kovanen, P. T., Kuivenhoven, J. A., Lesnik, P., Masana, L., Nordestgaard, B. G., Ray, K. K., Reiner, Z., Taskinen, M.-R., Tokgözoglu, L., Tybjærg-Hansen, A., & Watts, G. F. (2011). Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management. European Heart Journal, 32(11), 1345–1361. https://doi.org/10.1093/eurheartj/ehr112

Chicago

Chapman, M John, Henry N Ginsberg, Pierre Amarenco, Felicita Andreotti, Jan Borén, Alberico L Catapano, Olivier S Descamps, et al. 2011. “Triglyceride-Rich Lipoproteins and High-Density Lipoprotein Cholesterol in Patients at High Risk of Cardiovascular Disease: Evidence and Guidance for Management.” European Heart Journal 32 (11): 1345–61. doi:10.1093/eurheartj/ehr112.